)
Snezana Milutinovic
Associate Director, Translational Research,
Radionetics Oncology
Milutinovic has 20 years of experience in diverse oncology research areas and has been involved in driving several biologic and small molecule therapeutics into FIH studies. Deep understanding and experience in evaluating different target classes and resistance mechanisms has enabled her to identify strongly synergistic drug combinations and influence clinical strategies for patients with unmet needs.